BMS, CBS Focus on PAT to Save Biopharm Big Bucks

In September, a new Center for Bioanalytical Sciences will start up, involving Bristol-Myers Squibb Co., Dublin City University and the National University of Ireland, Galway. BMS predicts the technologies being developed could reduce biopharmaceutical production costs by $80 million per year for a typical medium to large processing line.

By Agnes Shanley, Editor in Chief

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments